Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
Meron Teklu, Philip M Parel, Nehal N Mehta National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USACorrespondence: Nehal N MehtaLasker Senior Investigator, Chief, Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung and Blood Institute, Nation...
Guardado en:
Autores principales: | Teklu M, Parel PM, Mehta NN |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4409475cc7bb458088cfff6be20c97bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
por: Betul Tas, et al.
Publicado: (2021) -
Current knowledge on psoriasis and autoimmune diseases
por: Ayala-Fontánez N, et al.
Publicado: (2016) -
Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016) -
Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Aimilios Lallas, et al.
Publicado: (2016) -
Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021)